Hospice in-patient deep vein thrombosis detection study
- Conditions
- Femoral deep vein thrombosis (DVT) in cancer patients admitted to specialist palliative care units (SPCUs).Circulatory System
- Registration Number
- ISRCTN97567719
- Lead Sponsor
- niversity of Hull
- Brief Summary
2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30709436 results 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/32046963/ exploratory substudy was the prevalence of DVT in patients with non-malignant palliative conditions (added 06/09/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 343
1. Admitted to a participating SPCU
2. 18 years or older
3. Able to give fully informed written consent or an available nominated consultee
4. No physical limitations to performing the ultrasound assessment
1. Patients on other clinical trials will be considered on a case by case basis
2. Patients who are considered by the clinical team likely to die within 5 days
3. Where, in the case of a patient without mental capacity, the nominated consultee is too distressed to be approached regarding the study in the opinion of the clinical team
4. Patients unable to understand English well enough to provide informed consent or comply with study assessments
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The prevalence of femoral DVT in cancer patients admitted to specialist palliative care unit (SPCU) measured by Doppler ultrasound
- Secondary Outcome Measures
Name Time Method 1. Incidence of developing a proximal lower limb DVT in patients with and without a diagnosis of cancer during admission to a SPCU<br>2. Prevalence of clinical symptoms and signs attributable to VTE (proximal lower limb DVT and PE) on admission to a SPCU<br>3. Incidence of clinical symptoms and signs attributable to VTE (proximal lower limb DVT and PE) during admission to a SPCU<br>4. Incidence of acute deterioration or sudden death in patients with a known DVT that could be attributed to clinical pulmonary emboli<br>5. Clinical characteristics associated with the presence or absence of proximal lower limb DVT<br>6. Association between use of anticoagulation and presence or absence of DVT on admission and during admission to a SPCU<br>7. Impact of proximal lower limb DVT on length of stay<br>8. Survival